Increased hepatocyte Fas expression and apoptosis in HIV and hepatitis C virus coinfection

被引:29
作者
Macías, J
Japón, MA
Sáez, C
Palacios, RB
Mira, JA
García-García, JA
Merchante, N
Vergara, S
Lozano, F
Gómez-Mateos, J
Pineda, JA
机构
[1] Hosp Univ Valme, Med Interna Serv, Unidad Enfermedades Infecciosas, Seville 41014, Spain
[2] Hosp Univ Virgen Rocio, Dept Anat Patol, Seville, Spain
关键词
D O I
10.1086/491736
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Chronic hepatitis C disease (CHC) follows an accelerated course in human immunodeficiency virus (HIV) coinfection. The reasons for this are unclear. Fas-mediated hepatocyte apoptosis is involved in the pathogenesis of hepatitis C virus (HCV) infection. We sought to compare the expression of Fas on hepatocytes and irreversible apoptosis of hepatocytes among patients with CHC with and without HCV/HIV coinfection. Methods. Fas-immunostained hepatocytes were semiquantified, and apoptotic hepatocytes were detected by staining caspase-cleaved cytokeratin 18 filaments and counted across the entire section of liver-biopsy specimens from HCV-infected patients with and without HCV/HIV coinfection. Results. One hundred thirty-four HCV/HIV-coinfected and 100 HCV-infected patients were included. HCV/ HIV coinfection was associated with both diffuse distribution of Fas-stained hepatocytes ( adjusted odds ratio [AOR], 7.4 [ 95% confidence interval {CI}, 3.8 - 14.4]) and with apoptotic hepatocyte counts greater than the median (AOR, 2.5 [95% CI, 1.5 - 4.5]). In HCV/ HIV-coinfected patients, CD4(+) cell nadir < 200 cells/mL was associated with both Fas expression (AOR, 2.9 [ 95% CI, 1.3 - 6.8]) and hepatocyte apoptosis ( AOR, 2.3 [ 95% CI, 1.1 - 4.9]). Conclusion. HCV/ HIV-coinfected patients show higher levels of hepatocytes expressing Fas and undergoing irreversible apoptosis than do HCV-infected patients. However, low CD4(+) cell nadirs in coinfected patients are associated with hepatocyte Fas expression and apoptosis.
引用
收藏
页码:1566 / 1576
页数:11
相关论文
共 35 条
  • [1] Caspase activation correlates with the degree of inflammatory liver injury in chronic hepatitis C virus infection
    Bantel, H
    Lügering, A
    Poremba, C
    Lügering, N
    Held, J
    Domschke, W
    Schulze-Osthoff, K
    [J]. HEPATOLOGY, 2001, 34 (04) : 758 - 767
  • [2] Factors affecting liver fibrosis in human immunodeficiency virus- and hepatitis C virus-coinfected patients: Impact of protease inhibitor therapy
    Benhamou, Y
    Di Martino, V
    Bochet, M
    Colombet, G
    Thibault, V
    Liou, A
    Katlama, C
    Poynard, T
    [J]. HEPATOLOGY, 2001, 34 (02) : 283 - 287
  • [3] Liver cell apoptosis in chronic hepatitis C correlates with histological but not biochemical activity or serum HCV-RNA levels
    Calabrese, F
    Pontisso, P
    Pettenazzo, E
    Benvegnù, L
    Vario, A
    Chemello, L
    Alberti, A
    Valente, M
    [J]. HEPATOLOGY, 2000, 31 (05) : 1153 - 1159
  • [4] Hepatocyte proliferation and apoptosis in relation to oxidative damage in alcohol-related liver disease
    Cardin, R
    D'errico, A
    Fiorentino, M
    Cecchetto, A
    Naccarato, R
    Farinati, F
    [J]. ALCOHOL AND ALCOHOLISM, 2002, 37 (01): : 43 - 48
  • [5] Dual effect of ethanol on cell death in primary culture of human and rat hepatocytes
    Castilla, R
    González, R
    Fouad, D
    Fraga, E
    Muntané, J
    [J]. ALCOHOL AND ALCOHOLISM, 2004, 39 (04): : 290 - 296
  • [6] Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-β, PGE2, and PAF
    Fadok, VA
    Bratton, DL
    Konowal, A
    Freed, PW
    Westcott, JY
    Henson, PM
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (04) : 890 - 898
  • [7] Ferenbach DA, 1997, J PATHOL, V183, P299
  • [8] Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.
    Fried, MW
    Shiffman, ML
    Reddy, KR
    Smith, C
    Marinos, G
    Goncales, FL
    Haussinger, D
    Diago, M
    Carosi, G
    Dhumeaux, D
    Craxi, A
    Lin, A
    Hoffman, J
    Yu, J
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (13) : 975 - 982
  • [9] Influence of hepatitis C virus coinfection on failure of HIV-infected patients receiving highly active antiretroviral therapy to achieve normal serum β2microglobulin levels
    García-García, JA
    Mira, JA
    Fernández-Rivera, J
    Ramos, AJ
    Vargas, J
    Macías, J
    Pineda, JA
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2003, 22 (03) : 194 - 196
  • [10] Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: A meta-analysis
    Graham, CS
    Baden, LR
    Yu, E
    Mrus, JM
    Carnie, J
    Heeren, T
    Koziel, MJ
    [J]. CLINICAL INFECTIOUS DISEASES, 2001, 33 (04) : 562 - 569